Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: July 2013

NJ Department of Health Joins Forces with 2014 NY/NJ Super Bowl Host Committee to Promote Blood Donation

Newark, NJ, July 30, 2013 — New Jersey Health Commissioner Mary E. O’Dowd is joining with the NY/NJ Super Bowl Host Committee and the New Jersey Workplace Blood Donor Coalition to call on New Jersey residents to donate blood to save lives and help patients who need transfusions for illnesses, surgeries and traumatic injuries.

The announcement, held during an employee blood drive at Johnson & Johnson’s world headquarters in New Brunswick, also highlighted the strength of Johnson & Johnson’s national Blood Drive Program. Continue reading

Institute for Infectious and Inflammatory Diseases to Be Established at Rutgers New Jersey Medical School

Newark, NJ, July 29, 2013 — Three Centers of Excellence at Rutgers New Jersey Medical School — the Public Health Research Institute (PHRI), the Center for Immunity and Inflammation and the Center for Emerging Pathogens — will combine to form a new institute to pursue novel approaches to detect, treat and prevent a wide range of current and emerging diseases caused by infectious agents and harmful inflammation.

The institute, to be known as the Institute for Infectious and Inflammatory Diseases (I³D), is expected to act as a springboard to further develop this already strong area of research excellence at Rutgers.   Continue reading

Rutgers Names Brian Strom as Chancellor of Biomedical and Health Sciences

New Brunswick, NJ, July 19, 2013 — Rutgers University President Robert L. Barchi yesterday announced the appointment of Brian L. Strom, M.D., M.P.H. — a renowned epidemiologist, award-winning teacher and clinician, and longtime academic leader at the University of Pennsylvania — as the inaugural chancellor of Rutgers Biomedical and Health Sciences (RBHS).  Dr. Strom will begin on December 2.

In making the announcement, President Barchi said, “I have known Dr. Strom for many years.  He is an internationally recognized scholar and researcher, a distinguished educator and a proven academic administrator.  His leadership will guide Rutgers Biomedical and Health Sciences during this unprecedented transition and establish RBHS as a model for research and education in the biomedical and health sciences.  Brian has enjoyed a remarkable career at Penn, and his vision and leadership will be invaluable as the new Rutgers transforms higher education in New Jersey.” Continue reading

HINJ Lauds Congressman Lance for FDA SOS Sponsorship

New Brunswick, NJ, July 18, 2013 ― HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas issued the following statement in response to Congressman Leonard Lance’s (R-NJ-7) introduction of the FDA SOS (Safety Over Sequestration) Act:

*     *     *

“New Jersey’s biopharmaceutical and medical technology companies applaud Congressman Lance for his leadership in ensuring that industry-paid user fees collected by the Food and Drug Administration (FDA) will be available to evaluate new medicines and medical devices that will benefit patients in the United States. Continue reading

Commissioner O’Dowd Calls on Businesses to Contribute to Efforts to Improve Health

Montclair, NJ, July 18, 2013 — Andrew Kitchenman reports in today’s NJ Spotlight that if New Jersey workers are going to get healthier, they have the best chance of changing unhealthy habits where they spend much of their time: at work.

That’s why state Health Commissioner Mary E. O’Dowd urged a group of business leaders yesterday to take steps to help their employees improve their health. Continue reading

Star-Ledger Editorial: NJ Report on Prescription Drug Abuse Is Call to Action for Reform

Newark, NJ, July 12, 2013The Star-Ledger today published an editorial regarding the State of New Jersey Commission of Investigation report, “Scenes from an Epidemic.”  The report, which was released yesterday, details the spreading illegal trade of prescription drugs and consequent spike in heroin abuse. Continue reading

HINJ and BioNJ Commentary: Cost-Cutting Measures Could Stifle Biopharmaceutical Innovation in NJ

Cherry Hill, NJ, July 10, 2013The Courier-Post has published a commentary authored by Dean J.  Paranicas, HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer, and Debbie Hart, BioNJ President and Chief Executive Officer.  

*     *     *

New Jersey officials recently announced a plan to reward companies that hire unemployed biopharmaceutical workers.  This move shows leaders recognize the importance of these highly skilled workers.

Already, New Jersey leads the nation in biopharmaceutical research.  It is home to more than 350 research-based biotechnology firms and 15 of the world’s 25 largest pharmaceutical companies. Continue reading

New Jersey Gives Innovation a Zone of Its Own; Focus on Academic, Corporate and State Collaboration

Montclair, NJ, July 8, 2013 — In a lengthy NJ Spotlight story, Tara Nurin reports that, as New Jersey looks for new ways to attract and retain high-paying jobs in a climate where seemingly every state competes for the same or similar companies, legislators and pro-business forces are heavily promoting collaboration between academia and industry as a way to attract investment and cut the time it takes to get a product or process out of the lab.

Increasingly, the state is offering tax credits and other incentives to encourage businesses to locate near universities.  The result, Nurin reports, is an “innovation zone,” where institutions of higher education lend research, facilities, and talent to neighboring companies, with the goal of reducing time to market — and time to profit. Continue reading

Princeton Researchers Use 3-D Printer to Create ‘Bionic Ear’

Princeton, NJ, July 5, 2013 — The Associated Press reports that, with a 3-D printer, a petri dish and some cells from a cow, Princeton University researchers are growing synthetic ears that can receive — and transmit — sound.

The scientists send bovine cells mixed in a liquid gel through the printer, followed by tiny particles of silver.  The printer is programmed to shape the material into a “bionic ear,” and forms the silver particles into a coiled antenna.  Like any antenna, this one can pick up radio signals that the ear will interpret as sound. Continue reading

Rutgers Now Among Top 25 Research Universities in U.S.

Princeton, NJ, July 2, 2013Choose New Jersey reports that, after merging the University of Medicine and Dentistry of New Jersey (UMDNJ) with Rutgers, the State University of New Jersey, the new Rutgers now has 65,000 students and a $3 billion budget.  

With an expanded focus on biotechnology and medical education, Rutgers is one of only two universities in the country with two medical schools and now has more research spending than Harvard, Yale or Northwestern. Continue reading